Group 1 - The market regulatory authority has intensified supervision in key livelihood areas such as healthcare, pharmaceuticals, medical devices, food, and children's myopia prevention, announcing ten typical cases of illegal advertising [1][2] - Guangzhou Jianmei Health Technology Co., Ltd. was fined 600,000 yuan for false advertising claims regarding children's eye health products, including "children's lutein" and "eye nose probiotics" [1] - Nala Zun Camel (Guangzhou) Dairy Co., Ltd. was fined 450,000 yuan for misleading claims in its advertising of "camel milk powder" related to disease prevention and treatment [1] - Inner Mongolia Caozhilou Biotechnology Co., Ltd. was fined 200,000 yuan for advertising "organic perilla seed oil" with claims of cancer prevention [1] Group 2 - Chongqing Linhui Tai Business Information Consulting Co., Ltd. was fined 160,000 yuan for advertising "986 germ life enzyme" and other products with false claims about treating serious diseases [2] - Hangzhou Qingbi Brand Management Co., Ltd. was fined 190,000 yuan for misleading claims in advertisements for various health products, including "myopia astigmatism lutein eye patches" [2] - Songyuan Anorectal Hospital was fined 100,000 yuan for false claims regarding its affiliation with reputable medical institutions, affecting public trust and safety [2] Group 3 - Yunnan Yuyao Biopharmaceutical Co., Ltd. was fined 100,000 yuan for violating advertising regulations by promoting a prescription drug, "Sanqi Fatty Liver Pill," inappropriately [3]

Core Viewpoint - The article highlights the increasing regulatory scrutiny on misleading advertisements in key consumer sectors such as healthcare, pharmaceuticals, medical devices, and food, particularly focusing on children's eye care and cancer treatment products. Group 1: Misleading Advertisements - Guangzhou Jianmei Health Technology Co., Ltd. was fined 600,000 yuan for advertising products like "children's lutein" and "eye protection lamp" with false claims about disease prevention and treatment [1] - Nala Zun Tuo (Guangzhou) Dairy Co., Ltd. faced a fine of 450,000 yuan for misleading claims in its "camel milk powder" advertisements regarding health benefits [1] - Jingdezhen Yuxin Yicai Ceramics Co., Ltd. was fined 287,200 yuan for misleading consumers by falsely advertising its ceramic tableware as "Jingdezhen porcelain" [1] Group 2: Health Claims in Food Products - Inner Mongolia Caozhilou Biotechnology Co., Ltd. was fined 200,000 yuan for advertising "organic perilla seed oil" with claims of cancer prevention and treatment [2] - Chongqing Linhui Tai Business Information Consulting Co., Ltd. was fined 160,000 yuan for promoting products like "986 germ life enzyme" with false health claims and misleading language [2] - Hangzhou Qingbi Brand Management Co., Ltd. was fined 190,000 yuan for advertising "nearsightedness and astigmatism eye patches" with exaggerated claims about restoring vision [2] Group 3: Real Estate and Medical Device Misleading Claims - Anhui Kangqiao Real Estate Co., Ltd. was fined 150,000 yuan for misleading advertising regarding unplanned facilities in its real estate promotions [3] - Shandong Chengshi Chengshi E-commerce Co., Ltd. was fined 105,000 yuan for advertising unapproved medical devices and health claims related to digestive issues [3] - Yunnan Yuyao Biopharmaceutical Co., Ltd. was fined 100,000 yuan for violating advertising regulations for prescription drugs [3] Group 4: Regulatory Actions - In 2025, national market regulatory authorities handled 44,521 cases of advertising violations, imposing fines totaling 252 million yuan, reinforcing consumer rights protection [4]

北京商报讯（记者 王寅浩 宋雨盈）1月31日，国家市场监督管理总局公布违法广告典型案例，内蒙古草 之楼生物科技有限公司因普通商品广告中含有涉及疾病预防、治疗功效的内容，被内蒙古自治区呼和浩 特市赛罕区市场监管局罚款。 据悉，内蒙古草之楼生物科技有限公司以直播形式发布的"有机紫苏籽油α—亚麻酸"普通食品广告中含 有"改善、缓解、抗癌"等涉及疾病预防、治疗功效的内容。2025年12月，内蒙古自治区呼和浩特市赛罕 区市场监管局依据《中华人民共和国广告法》有关规定，对该公司作出罚款20万元的行政处罚。 ...

Core Viewpoint - In 2025, the National Market Supervision Administration handled a total of 44,521 advertising violation cases, imposing fines totaling 252 million yuan, effectively strengthening consumer rights protection [1]. Group 1: Advertising Violations - Guangzhou Jianmei Health Technology Co., Ltd. was fined 600,000 yuan for false advertising claims regarding its products, including misleading statements about health benefits and the involvement of international medical experts [1]. - Nala Zun Tuo (Guangzhou) Dairy Co., Ltd. faced a fine of 450,000 yuan for advertising its camel milk powder with false claims related to health improvements and misleading promotional content [2]. - Jingdezhen Yuxin Yicai Ceramics Co., Ltd. was fined 287,200 yuan for misleading consumers by falsely advertising its ceramic products as being from Jingdezhen [3]. - Inner Mongolia Caozhilou Biotechnology Co., Ltd. was fined 200,000 yuan for advertising its organic perilla seed oil with unverified health claims [4]. - Chongqing Linhui Tai Business Information Consulting Co., Ltd. was fined 160,000 yuan for using exaggerated claims in its advertisements for various health products [5]. - Hangzhou Qingbi Brand Management Co., Ltd. was fined 190,000 yuan for advertising products with unsubstantiated health benefits [7]. - Anhui Kangqiao Real Estate Co., Ltd. was fined 150,000 yuan for misleading advertising related to real estate developments [8]. - Shandong Chengshi Chengshi E-commerce Co., Ltd. was fined 105,000 yuan for advertising unapproved medical devices and health products with false claims [9]. - Songyuan Anorectal Hospital was fined 100,000 yuan for misleading advertising regarding its medical services [10]. - Yunnan Yuyao Biological Pharmaceutical Co., Ltd. was fined 100,000 yuan for violating advertising regulations related to prescription drugs [11]. Group 2: Regulatory Actions - In 2025, the National Market Supervision Administration launched a nationwide campaign to rectify advertising market order, focusing on key areas such as healthcare, pharmaceuticals, medical devices, food, and children's vision protection [10]. - The campaign aimed to combat misleading health claims in ordinary food advertisements, illegal live-streaming of advertisements, and false citation content [10]. - A significant number of illegal advertisements related to children's eye protection, cancer treatments, longevity products, and counterfeit medical professionals were targeted during this campaign [10].

Core Viewpoint - In 2025, the National Market Supervision Administration handled a total of 44,521 advertising violation cases, imposing fines totaling 252 million yuan, effectively strengthening consumer rights protection. Group 1: Advertising Violations - Guangzhou Jianmei Health Technology Co., Ltd. was fined 600,000 yuan for false advertising claims regarding eye health products, including misleading statements about preventing myopia and promoting false endorsements from international ophthalmologists [1]. - Nala Zun Tuo (Guangzhou) Dairy Co., Ltd. faced a fine of 450,000 yuan for advertising camel milk powder with false claims related to health benefits and misleading promotional content [2]. - Jingdezhen Yuxin Yicai Ceramics Co., Ltd. was fined 287,200 yuan for misleading consumers by falsely advertising ceramic tableware as being produced in Jingdezhen [3]. - Inner Mongolia Caozhilou Biotechnology Co., Ltd. was fined 200,000 yuan for advertising organic perilla seed oil with unverified health claims [4]. - Chongqing Linhui Tai Business Information Consulting Co., Ltd. was fined 160,000 yuan for promoting various health products with exaggerated claims about their efficacy [5]. - Hangzhou Qingbi Brand Management Co., Ltd. was fined 190,000 yuan for advertising eye health patches with unsubstantiated claims about restoring vision [6][7]. - Anhui Kangqiao Real Estate Co., Ltd. was fined 150,000 yuan for misleading advertising related to real estate development [8]. - Shandong Chengshi Chengshi E-commerce Co., Ltd. was fined 105,000 yuan for advertising unapproved medical devices and making false health claims [9]. - Songyuan Anorectal Hospital was fined 100,000 yuan for misleading advertising regarding its medical qualifications [10]. - Yunnan Yuyao Biological Pharmaceutical Co., Ltd. was fined 100,000 yuan for violating advertising regulations for prescription drugs [10]. Group 2: Regulatory Actions - In 2025, the National Market Supervision Administration launched a nationwide campaign to rectify advertising market order, focusing on key areas such as healthcare, pharmaceuticals, medical devices, food, and children's vision protection [10].

Core Viewpoint - In 2025, the State Administration for Market Regulation (SAMR) conducted a nationwide campaign to rectify advertising market order, focusing on key livelihood areas such as healthcare, pharmaceuticals, medical devices, food, and children's myopia prevention, resulting in the investigation of 44,521 advertising violations and fines totaling 252 million yuan [1] Group 1: Advertising Violations - Guangzhou Jianmei Health Technology Co., Ltd. was fined 600,000 yuan for misleading advertisements claiming health benefits related to eye care products [2] - Nala Zun Tuo (Guangzhou) Dairy Co., Ltd. faced a fine of 450,000 yuan for false claims regarding the health benefits of camel milk powder [2] - Jingdezhen Yuxin Yicai Ceramics Co., Ltd. was fined 287,200 yuan for misleading consumers by falsely advertising ceramic tableware as being from Jingdezhen [3] - Inner Mongolia Caozhilou Biotechnology Co., Ltd. was fined 200,000 yuan for advertising organic perilla seed oil with unverified health claims [4] - Chongqing Linhui Tai Business Information Consulting Co., Ltd. was fined 160,000 yuan for promoting various health products with exaggerated claims [5] - Hangzhou Qingbi Brand Management Co., Ltd. was fined 190,000 yuan for advertising eye care patches with unsubstantiated treatment claims [7] - Anhui Kangqiao Real Estate Co., Ltd. was fined 150,000 yuan for misleading real estate advertisements that included unapproved infrastructure claims [8] - Shandong Chengshi Chengshi E-commerce Co., Ltd. was fined 105,000 yuan for advertising unapproved medical devices and health products with false efficacy claims [9] - Songyuan Anorectal Hospital was fined 100,000 yuan for false advertising regarding its medical qualifications [10] - Yunnan Yuyao Biopharmaceutical Co., Ltd. was fined 100,000 yuan for advertising prescription drugs in violation of regulations [10]